CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 82  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0763
LYS 10.0086
GLU 20.0088
LEU 30.0098
ARG 40.0099
CYS 50.0062
GLN 60.0210
CYS 70.0294
ILE 80.0218
LYS 90.0560
THR 100.0315
TYR 110.0346
SER 120.0458
LYS 130.0763
PRO 140.0212
PHE 150.0163
HIS 160.0201
PRO 170.0122
LYS 180.0296
PHE 190.0106
ILE 200.0089
LYS 210.0242
GLU 220.0205
LEU 230.0158
ARG 240.0146
VAL 250.0213
ILE 260.0172
GLU 270.0185
SER 280.0076
GLY 290.0251
PRO 300.0116
HIS 310.0095
CYS 320.0078
ALA 330.0286
ASN 340.0153
THR 350.0093
GLU 360.0077
ILE 370.0079
ILE 380.0071
VAL 390.0055
LYS 400.0047
LEU 410.0043
SER 420.0081
ASP 430.0170
GLY 440.0119
ARG 450.0113
GLU 460.0080
LEU 470.0090
CYS 480.0125
LEU 490.0090
ASP 500.0144
PRO 510.0055
LYS 520.0129
GLU 530.0208
ASN 540.0172
TRP 550.0224
VAL 560.0102
GLN 570.0150
ARG 580.0037
VAL 590.0085
VAL 600.0134
GLU 610.0095
LYS 620.0146
PHE 630.0148
LEU 640.0113
LYS 650.0200
ARG 660.0143
ALA 670.0510
GLU 680.0339
ASN 690.0131

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.